Table 4 Serum BDNF concentrations (ng·ml− 1) across the course of the resting and exercise trials, for the high- and low-fitness groups, as well as the group overall. Data are mean ± SD
Group | Control Trial | Exercise Trial | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Pre-rest | Immediately post-rest | 30 min post-rest | 60 min post-rest | 120 min post-rest | Pre-exercise | Immediately post-exercise | 30 min post-exercise | 60 min post-exercise | 120 min post-exercise | |
Low-Fit | 28.7 ± 6.3 | 29.2 ± 7.4 | 28.8 ± 6.2 | 31.1 ± 6.0 | 30.2 ± 8.2 | 28.1 ± 5.5 | 31.0 ± 10.6 | 28.4 ± 9.2 | 27.2 ± 8.2 | 28.5 ± 9.9 |
High-Fit | 26.1 ± 5.0 | 26.3 ± 8.4 | 28.1 ± 6.7 | 29.3 ± 6.3 | 31.1 ± 7.3 | 23.4 ± 4.3 | 26.3 ± 7.2 | 26.8 ± 6.8 | 27.0 ± 5.9 | 26.3 ± 7.5 |
Overall | 27.4 ± 5.8 | 27.8 ± 8.0 | 28.5 ± 6.3 | 30.2 ± 6.1 | 30.6 ± 7.7 | 25.8 ± 5.4 | 28.6 ± 9.2 | 27.6 ± 8.0 | 27.1 ± 7.1 | 27.4 ± 8.7 |